RHEOMETRIC SCIENTIFIC INC
10-Q, 2000-01-28
MEASURING & CONTROLLING DEVICES, NEC
Previous: RHEOMETRIC SCIENTIFIC INC, 10-Q, 2000-01-28
Next: PRICE T ROWE GNMA FUND, NSAR-A, 2000-01-28






                          FORM 10-Q

                        UNITED STATES
             SECURITIES AND EXCHANGE COMMISSION
                   Washington, D.C.  20549
(Mark One)

[ X] QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE
     SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended: September 30, 1999

                             OR

[  ]  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
       OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from           to

Commission file number:  0-14617

                       RHEOMETRIC SCIENTIFIC, INC.
    (Exact name of registrant as specified in its charter)

          New Jersey                         61-0708419
 (State or other jurisdiction of    (I.R.S. Employer Identi-
     incorporation or organization)      fication Number)

     One Possumtown Road, Piscataway, NJ       08854-2103
    (Address of principal executive offices)  (Zip Code)

                           (732) 560-8550
    (Registrant's telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all
reports required to be filed by Section 13 or 15(d) of the
Securities Exchange Act of 1934 during the preceding 12 months
(or for such shorter period that the registrant was required to
file such reports), and (2) has been subject to such filing
requirements for the past 90 days.

                   Yes           No _X___

Indicate the number of shares outstanding of each of the
issuer's classes of common stock, as of the latest practicable
date.

      Class                       Outstanding at January 3, 2000
Common Stock, no par value                   13,161,739

                           1 of 16

<PAGE>
           RHEOMETRIC SCIENTIFIC, INC. AND SUBSIDIARIES
            CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands)            (Unaudited)

<TABLE>
<CAPTION>
                                             September    December
                                             30, 1999     31, 1998
                                             _________    _________
<S>                                          <C>          <C>
ASSETS

Current Assets
 Cash                                         $   628     $   488
 Accounts receivable, net                       9,753       9,817
 Inventories, net
  Finished goods                                2,776       3,491
  Work in process                               1,090       1,491
  Assembled components, materials, and parts    5,643       5,648
                                              _______     _______
                                                9,509      10,630
 Prepaid expenses and other assets                694         990
                                              _______     _______
  Total current assets                         20,584      21,925
                                              _______    ________
Property, plant, and equipment                 15,340      15,370
 Less accumulated depreciation and
  Amortization                                  9,846       9,524
                                              _______     _______
 Property, plant, and equipment, net            5,494       5,846
Other assets                                      851         763
                                              _______     _______
  Total Assets                                $26,929     $28,534
                                              =======     =======

LIABILITIES AND SHAREHOLDERS' EQUITY
Current Liabilities
 Short-term bank borrowings                    $5,774     $ 5,718
 Current maturity of long-term debt               198         242
 Accounts payable                               1,878       2,381
 Borrowings against accounts receivable           778         874
Payable to affiliate                              752          --
Accrued liabilities                             3,590       3,267
                                              _______     _______
  Total current liabilities                    12,970      12,482
                                              _______     _______

Long-term debt lease obligation                 4,568       4,643
Long-term debt - affiliate                      6,258       6,258
Payable to affiliate                            1,948       1,948
Long-term liability - Mettler                   1,015       1,336
Other long-term liabilities                        32         102

  Total liabilities                            26,791      26,769
                                              _______     _______
Commitments and Contingencies

Shareholders' Equity
 Common stock, stated value of $.001,
  Authorized 20,000 shares; issued and
  Outstanding 13,162 shares                        13          13
 Additional paid-in capital                    25,523      25,523
 Accumulated deficit                          (25,439)    (23,691)
 Accumulated other comprehensive income/(loss)     41         (80)
                                              _______     _______
  Total shareholders' equity                      138       1,765
                                              _______     _______
   Total Liabilities & Shareholders' Equity   $26,929     $28,534
                                              =======     =======
</TABLE>

See Notes to Condensed Consolidated Financial Statements.

                           2 of 16
<PAGE>

            RHEOMETRIC SCIENTIFIC, INC. AND SUBSIDIARIES
           CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
                (In thousands, except per share data)
                             (Unaudited)
<TABLE>
<CAPTION>
                                       Three Months Ended     Nine Months Ended
                                          September 30,           September 30,
                                      1999        1998         1999       1998
                                     ______       ______      ______     ______
<S>                                  <C>          <C>         <C>       <C>

Sales                                $ 6,939      $ 7,580     $20,630   $23,077
Cost of sales                          4,065        3,952      11,381    11,949
                                     _______      _______     _______   _______

Gross profit                           2,874        3,628       9,249    11,128
                                     _______      _______     _______   _______
General and administrative expenses      524          324       1,441       994

Marketing and selling expenses         2,173        1,959       6,202     6,559

Research and development expenses        526          583       1,603     1,677

Goodwill and intangible amortization      38           58         138       179

Total Operating Expenses               3,261        2,924       9,384     9,409
                                     _______      _______     _______  _______

Operating (loss)/income                 (387)         704        (135)    1,719

Interest expense                        (285)        (366)       (789)   (1,131)
Interest expense - Affiliate            (261)        (231)       (752)    (667)
Foreign currency gain/(loss)             228          179         (69)      46
                                     _______      _______     _______  _______

Loss before income taxes                (705)         286      (1,745)     (33)

Income tax expense                        (1)          (1)         (3)      (6)

Net (loss)/ income                    $ (706)     $   285     $(1,748)   $ (39)

Net (loss)/income per share
  Basic                               $(0.05)     $  0.02     $ (0.13)   $(0.00)
  Diluted                             $(0.05)     $  0.02     $ (0.13)   $(0.00)
Average number of shares Outstanding
  Basic                               13,162       13,162      13,162    13,162
                                      ======       ======      ======   ======
  Diluted                             13,162       13,162      13,162    13,162
                                      ======       ======      ======   ======
</TABLE>

See Notes to Condensed Consolidated Financial Statements.

                               3 of 16
<PAGE>

                   RHEOMETRIC SCIENTIFIC, INC.
         CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
 (In thousands)           (Unaudited)

<TABLE>
<CAPTION>
                                                    Nine Months Ended
                                                    September 30,
                                                  1999        1998
                                                 _______    ________
<S>                                            <C>          <C>
Cash Flows from Operating Activities:
Net loss                                       $(1,748)     $   (39)
Adjustments to reconcile net loss to
 net cash (used in)/provided by
 operating activities:
 Depreciation and amortization of plant and
  Equipment                                         492         576
Amortization of goodwill and intangibles            138         179
Provision for inventory reserves                    502         373
Unrealized currency (gain)/loss                     (15)       (150)
 Loss on sale/retirement of plant and equipment       4           2
 Warrants issued                                     --          31
Changes in assets and liabilities:
 Accounts receivable                                111       4,055
 Inventories                                        575        (666)
 Prepaid expenses and other current
  Assets                                            296         (51)
 Restructuring                                       --        (629)
 Payable to affiliate                               752         667
Accounts payable and accrued
  Liabilities                                      (137)     (2,148)
 Other assets                                      (212)          1
 Other non-current liabilitis                      (202)         64
                                                _______     _______

Net cash provided by operating activities           556       2,265
                                                _______     _______
Cash Flows from Investing Activities:

 Purchases of property, plant, and equipment        (69)        (43)
                                                _______     _______
Net cash used in investing activities               (69)        (43)
                                                _______     _______

Cash Flows from Financing Activities:
Net (repayment)/borrowings under line of
  credit agreements                                 (73)     (1,596)
                                                _______     _______
Net (repayments)/borrowings against
  accounts receivables                             (145)       (378)
Repayment of long-term debt/lease obligation       (193)       (169)
                                                _______     _______

Net cash used in financing
 Activities                                        (411)     (2,143)
                                                _______     _______

Effect of exchange rate changes on cash              64         (33)
                                                _______     _______
Net increase in cash                                140          46

Cash at beginning of period                         488         297
                                                _______      ______

Cash at end of period                            $  628      $  343
                                                =======     =======
Cash payments for interest                       $1,003      $1,224
                                                =======     =======
Cash payments for income taxes                   $  188      $  137
                                                =======     =======
</TABLE>

See Notes to Condensed Consolidated Financial Statements.

                             4 of 16
<PAGE>

        RHEOMETRIC SCIENTIFIC, INC. AND SUBSIDIARIES
  CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
            (In thousands, except per share data)
                         (Unaudited)
<TABLE>
<CAPTION>
                                          Three Months         Nine Months
                                      Ended September 30,  Ended September 30,

                                      1999         1998    1999         1998
                                     _______     _______  _______     _______
<S>                                  <C>         <C>      <C>         <C>

Net (loss)/income                    $ (706)     $  285    $(1,748)    $ (39)
Other comprehensive loss
  Foreign currency translation
    Adjustments                           9         (48)       121      (137)
                                     ______      ______     ______    ______
  Other comprehensive income/(loss)       9         (48)       121      (137)
                                     ______      ______     ______    ______
  Comprehensive income/(loss)        $ (697)     $  237     (1,627)   $ (176)
                                     ======      ======     ======    ======

</TABLE>

See Notes to Condensed Consolidated Financial Statements.




                 RHEOMETRIC SCIENTIFIC, INC.

    NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

1. Accounting Policies

  The information included in the foregoing interim financial
   statements is unaudited. In the opinion of management, all
   adjustments, consisting of normal recurring accruals,
   necessary for a fair presentation of financial position and
   results of operations for the interim periods presented have
   been reflected herein.  The results of operations for the
   interim periods are not necessarily indicative of the results
   to be expected for the entire year.

   In June 1997, the Financial Accounting Standards Board
   (FASB) issued Statement of Financial Accounting Standards
   (SFAS) No. 131, "Disclosures about Segments of an
   Enterprise and Related Information," for fiscal years
   beginning after December 15, 1997. The provisions of SFAS
   No. 131 establish standards for the way that enterprises
   report information about operating segments in annual
   financial statements and require that selected
   information about operating segments in interim financial
   statements be reported.  It also establishes standards
   for related disclosure about products and services,
   geographic areas, and major customers.  The Company has
   adopted these standards of disclosure for year end 1998
   and interim periods beginning in 1999.

  Effective January 1, 1998, the Company adopted Statement
  of Financial Accounting Standards (SFAS) No. 130,
  "Reporting Comprehensive Income."  The provisions of SFAS
  No. 130

                           5 of 16
  <PAGE>

  establish standards for reporting and display of
  comprehensive income and its components in the financial
  statements.  This statement requires all items that are
  required to be recognized under accounting standards as
  components of comprehensive income be reported in the
  financial statements and displayed with the same
  prominence as other financial statements.

   In June 1998, the Financial Accounting Standards Board
   (FASB) issued Statement of Financial Accounting Standards
   (SFAS) No. 133, "Accounting for Derivative Instruments
   and Hedging Activities," for fiscal years beginning after
   June 15, 2000.  The provisions of SFAS No. 133 require
   all derivatives to be recognized in the statement of
   financial position as either assets or liabilities and
   measured at fair value.  In addition, all hedging
   relationships must be designated, reassessed and
   documented pursuant to the provisions of SFAS 133.  At
   present time the Company is reviewing the potential
   impact of this standard.

2.   Loss Per Share

  In February 1997, the Financial Accounting Standards Board
  issued Statement of Financial Accounting Standards No. 128,
  "Earnings Per Share" ("SFAS No. 128").  SFAS 128 establishes
  standards for computing and presenting earnings per share
  ("EPS") and supersedes APB Opinion No. 15.  "Earnings per
  Share" ("Opinion 15").  SFAS 128 replaces the presentation of
  primary EPS with a presentation of basic EPS which excludes
  dilution and is computed by dividing income available to
  common stockholders by the weighted-average number of common
  shares outstanding during the period.  Diluted reflects the
  potential dilution that could occur if outstanding options and
  warrants were exercised. This statement has no effect on the
  Company's prior period EPS data.

3.   Long-term Debt and Short-term Borrowings

   Long-term debt consists of the following:

<TABLE>
<CAPTION>

                                         September 30, 1999  December 31, 1998
   <S>                                     <C>                 <C>
Obligation under sale/leaseback
  payable through February 2011,
  with interest imputed at a weighted-
  average rate of 13.9% for 1999
  and 1998, respectively                    $4,758,000          $4,806,000

Note payable through November
   1999 with interest at 9.54%                   8,000              79,000
                                            __________          __________
                                             4,766,000           4,885,000
Less current maturities                        198,000             242,000
                                            __________         ___________
                                            $4,568,000          $4,643,000
                                            ==========         ===========
</TABLE>
                           6 of 16

<PAGE>

   The Company at September 30, 1999 had working capital
   lines of credit with certain domestic and foreign banks.
   The foreign working capital lines of credit were
   supported by letters of credit issued under the Company's
   Loan and Security Agreement, as amended, (the "Loan
   Agreement").  Total borrowings were $5,774,000 with
   remaining availability of approximately $790,000 as of
   September 30, 1999. Interest on the domestic line of
   credit at September 30, 1999 and December 31, 1998 was
   9.75% and 9.25% respectively.  Interest rates on the
   foreign lines of credit ranged between 1.5% and 8.0% as
   of September 30, 1999 and 1.9% and 8.0% as of December
   31, 1998.

   The Loan Agreement requires the Company to maintain a
   minimum tangible net worth and working capital, generate
   minimum consolidated and domestic cash flows, and achieve
   a minimum adjusted funded debt to adjusted tangible net
   worth ratio.  In addition, the Loan Agreement prohibits
   the payment of cash dividends or cash distributions to
   shareholders.  During the first three quarters of 1999
   the Company had been in violation of certain debt
   covenants and has obtained waivers covering these
   violations.

   The Company's lines and letters of credit are subject to
   acceleration in the event that there is a material and
   adverse change in the condition or affairs, financial or
   otherwise, of the Company which in the reasonable opinion
   of the lender impairs the lender's collateral or
   increases its risk so as to jeopardize the repayment of
   the obligations.

   On August 12, 1998, the Company was notified by its
   lender that the Company's Loan and Security Agreement
   (the "Loan Agreement") would not be extended beyond the
   expiration date of February 23, 1999.  Following that
   notification, the Company commenced discussions with
   other prospective lenders to replace the credit facility
   provided by the Loan Agreement with a credit facility
   with a maximum available credit of $10,000,000.  This
   credit facility would take advantage of both the domestic
   and foreign receivables in calculating the borrowing
   base.  The ability to proceed with a lesser maximum
   credit than available under the current Loan Agreement is
   based on existing improvements in the management of the
   Company's working capital.

   On February 19, 1999, the Loan Agreement was amended so
   as to extend the Loan Agreement to May 21, 1999.  In
   addition, the facility limit was permanently reduced to
   $10,000,000 and the inventory sublimit would continue to
   be permanently and automatically decreased by $25,000
   each week.  The Loan Agreement was further extended for
   one-month periods to June 25, July 26, August 30,
   September 30 and then to October 31, 1999.

                           7 of 16
<PAGE>

   On November 12, 1999 the Company's lender amended the
   Loan Agreement extending its term to November 30, 2000.
   As of this date, all foreign lines of credit have been
   consolidated into the domestic line of credit and the
   foreign receivables are no longer used in the calculation
   of the borrowing base.  Foreign working capital
   requirements will be satisfied by cash generated from
   current operations. In addition, the facility limit was
   permanently reduced to $6,500,000 and the inventory
   sublimit would continue to be permanently and
   automatically decreased by $25,000 each week. The advance
   rate of 69% on eligible receivables will be reduced in
   March 2000 to 61% and then further decreased 2% each
   month thereafter.  Covenant requirements have been
   revised based on the Company's forecast for 2000.

4.   Operating Segments/Foreign Operations and Geographic
  Information

   Effective December 31, 1998 the Company adopted SFAS 131
   "Disclosures about Segments of an Enterprise and Related
   Information."  Prior year information has been restated
   to present the Company's three reportable segments:
   Domestic, Europe, and the Far East.  The accounting
   policies of the reportable segments are the same as those
   described in the Summary of Significant Accounting
   Policies.  The Company evaluates the performance of its
   operating segments based on revenue performance and
   operating income.  Summarized financial information
   concerning the Company's reportable segments is shown
   below:

<TABLE>
<CAPTION>

(In thousands)       Domestic    Europe       Japan   Consolidated
                    _________   _________   _________   _________

<S>                   <C>         <C>        <C>          <C>
Trade Sales:
 9/30/99              10,756      4,777      5,097        20,630
 9/30/98              12,335      5,763      4,979        23,077

Intercompany Sales:
 9/30/99               4,381        837          0        -----
 9/30/98               6,537        882          0        -----

Operating Income:
 9/30/99                 366       (934)       433          (135)
 9/30/98               3,813     (2,141)        47         1,719

Identifiable Assets:
 9/30/99              23,456     (1,034)     4,507        26,929
 9/30/98              28,046        365      2,956        31,367

Depreciation and Amortization:
  9/30/99                420         55         17           492
  9/30/98                440        115         21           576

</TABLE>

                           8 of 16

<PAGE>

Sales between geographic areas are priced on a basis that
yields an appropriate rate of return based on assets
employed, risk and other factors.


ITEM 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF RESULTS OF
OPERATIONS AND FINANCIAL CONDITION

Results of Operations

Sales for the three- and nine-month period ended September
30, 1999 decreased $641,000 and $2,447,000 (or 8.5% and
10.6%), respectively, as compared to the corresponding
period in 1998.  These figures include a positive impact of
$179,000 and $476,000 on sales for the three and nine months
ended September 30, 1999 due to favorable currency rates in
effect compared to last year.  The decline in revenue for
the nine-month period resulted from a decrease in the
Americas and Europe of $1,579,000 and $986,000 respectively,
offset by an increase in Japan of $118,000.  The decline in
revenue for the three-month period represents a decrease in
Japan and Europe of $86,000 and $658,000 respectively,
offset by an increase in the Americas of $103,000.  For the
nine-month period, total international sales of $9,874,000
represented 47.9% of total sales compared to 1998
international sales of $10,742,000 that amounted to 46.5% of
total sales.  The gross profit percentages for the three and
nine-months ended September 30, 1999 were 46.5% and 46.6%
respectively.  This compares to 52.8% and 49.8% for the same
periods in the prior year.

Operating expenses for the three and nine months ended
September 30, 1999 were up $337,000 and down $25,000
respectively compared to the corresponding periods in the
prior year.  The increase in expenses is the result of one-
time credits that were recorded in 1998 totaling
approximately $300,000.  Excluding these one-time credits,
operating expenses for the three-month period would be up
$37,000 while expenses for the nine-month period would be
down $325,000. The increase for the three-month period is
due to higher advertising expenses compared to last year.
The decrease in the nine-month period is due to cost
reduction measures that the company had taken in 1998. For
both the three and nine-month periods, operating expenses
were unfavorably affected by foreign currency trends of
$74,000 and $150,000 respectively.

Net interest expense for the three and nine months ended
September 30, 1999 decreased $51,000 and $257,000
respectively, compared to the corresponding period in the
prior year.  These decreases are the result of carrying
lower loan balances for the three and nine-month periods.

The Company is exposed to foreign currency gains and losses
related to its intercompany payables and another payable to

                           9 of 16

<PAGE>

Mettler Toledo AG, pursuant to the exclusive world-wide
property rights agreement between the Company and Mettler,
which is due in Swiss Francs.  The Company's foreign
currency exposure policy is to not enter into foreign
currency derivative instruments.

The foreign currency adjustments for the three and nine
months ended September 30, 1999 totaled a gain of $228,000
and a loss of $69,000, respectively.  The year-to-date adjustment
was primarily due to transaction losses of $259,000 resulting
from the German Mark, French Franc, Japanese Yen, and British Pound
against the U.S. Dollar.  These were offset by an unrealized gain of
$190,000 resulting from the Swiss Franc against the U.S. Dollar.

Inherent in the Company's business is the potential for
inventory obsolescence for older products as the Company
develops new products.  Obsolescence has historically related
to parts inventory.  The Company continuously monitors its
exposure relating to excess and obsolete inventory and
establishes what in management's judgment at the time are
appropriate valuation reserves.

Liquidity and Capital Resources

Management believes that cash generated from operations and
funds available under lines of credit should be sufficient
to meet the Company's working capital needs for the next
year.  Adequacy of cash flows beyond that period will depend
upon the Company's ability to achieve expected sales volumes
to support profitable operations.

On February 23, 1996 the Company entered into a three-year
Loan and Security Agreement (the "Loan Agreement").  The
Loan Agreement provides a working capital revolving credit
facility with a maximum available credit of $11,500,000.
The amount of available credit is determined by the level of
certain eligible receivables and inventories.  On March 31,
1998, the Company's bank amended the Loan Agreement with
regards to the facility limit and inventory sub-limit.
Effective April 1, 1998 and on the opening of business on
Wednesday of each consecutive week thereafter, both the
facility limit and the inventory sublimit will decrease by
$25,000.

The Company's Loan Agreement expired on February 23, 1999,
and the lender had notified the Company in August 1998 that
the Loan Agreement would not be extended beyond the
expiration date.  Following that notification, the Company
commenced discussions with other prospective lenders to
replace the credit facility with a maximum available credit
of $10,000,000. This credit facility would take advantage of
both the domestic and foreign receivables in calculating the
borrowing base.  The ability to proceed with a lesser
maximum credit is based on existing improvements in the
management of the Company's working capital.

                          10 of 16

<PAGE>

On February 19, 1999, the Loan Agreement was amended so as
to extend the Loan Agreement to May 21, 1999.  In addition,
the facility limit was permanently reduced to $10,000,000
and the inventory sub-limit would continue to be permanently
and automatically decreased by $25,000 each week.  The Loan
Agreement was further extended for one-month periods to June
25, July 26,  August 30, September 30 and then to October
31,1999.

The Company at September 30, 1999 had working capital lines
of credit with certain domestic and foreign banks.  The
foreign working capital lines of credit were supported by
letters of credit issued under the Company's Loan and
Security Agreement, as amended, (the "Loan Agreement").
Total borrowings were $5,774,000 with remaining availability
of approximately $790,000 at September 30, 1999. Interest on
the domestic line of credit at September 30, 1999 was 9.75%
and at December 31, 1998 was 9.25%.  Interest rates on the
foreign lines of credit ranged between 1.5% and 8.0% as of
September 30, 1999 and 1.9% and 8.0% as of December 31,
1998.

On November 12, 1999 the Company's lender amended the Loan
Agreement extending its term to November 30, 2000. As of
this date, all foreign lines of credit have been
consolidated into the domestic line of credit and the
foreign receivables are no longer used in the calculation of
the borrowing base.  Foreign working capital requirements
will be satisfied by cash generated from current operations.
In addition, the facility limit was permanently reduced to
$6,500,000 and the inventory sublimit would continue to be
permanently and automatically decreased by $25,000 each
week.  The advance rate of 69% on eligible receivables will
be reduced in March 2000 to 61% and then further decreased
2% each month thereafter.  Covenant requirements have been
revised based on the Company's forecast for 2000.


Cash Flows from Operations. Net cash provided by operating
activities during the nine months ended September 30, 1999
was $556,000.  This is a decrease of $1,709,000 over the
same period last year.  Net loss for the nine months ended
September 30, 1999 was $1,748,000 compared to $39,000 during
the same period last year. During the nine months ended
September 30, 1999, accounts receivable decreased by
$111,000 reflecting lower third quarter 1999 sales as
compared to the last quarter 1998 sales.  Inventories
decreased by $575,000 as a result of the Company's efforts
to better manage their inventory levels.  Management
continuously monitors inventory levels on a worldwide basis
in order to ensure that excess inventory is kept to a
minimum.  Other assets and payable to affiliate increased by
$212,000 and $752,000 respectively while prepaid expenses
and other non-current liabilities decreased by $296,000 and
$202,000 respectively.  Accounts payable and accrued
expenses decreased by $137,000.

                          11 of 16

<PAGE>

Cash Flows From Investing.  Net cash used in investing
activities during the nine months ended September 30, 1999
was $69,000 as compared to $43,000 during the same period in
1998.

Cash Flows From Financing.  Net cash used in financing
activities during the nine-month period ended September 30,
1999 was $411,000.  The Company's borrowing against its
accounts receivable during the nine-month period ended
September 30, 1999 decreased $145,000 and its borrowing
under line of credit agreements decreased $73,000.
Repayments of long term debt and the lease obligation total
$193,000 for the period.


Year 2000 Issues
Rheometric Scientific recognizes that its operations, as
well as those of its suppliers and customers are reliant
upon computer systems for many aspects of their business.
Computer programs and embedded computer chips that are not
Year 2000 compliant will not be able to distinguish between
the calendar years 1900 and 2000.  The Company acknowledges
that the Year 2000 situation could adversely impact its
operations and is implementing a comprehensive plan to
address all known aspects of the Year 2000 problem.

In a program that was started in 1997, the Company has
completed an inventory of information systems, production
and facilities equipment, products, customers, and suppliers
that may potentially have a Year 2000 problem.  The Company
has been formally addressing assessments, conversion plans
and conversion implementation and testing for all internal
systems running on a variety of computer platforms.
Approximately 90% of the internal systems conversions and
upgrades are completed.  Certain non-compliant systems are
being replaced or retired from service.  Converted programs
have been tested.  Software and equipment found to be not
Year 2000 compliant will be upgraded or replaced before the
end of the fourth quarter of 1999.

In addition to efforts regarding internal systems, the
Company has also been assessing its significant suppliers.
These suppliers include raw material, energy and production
supply providers, as well as suppliers of financial,
communication and logistics services.  The Company has
communicated with key suppliers and has sent questionnaires
to all critical suppliers regarding year 2000 readiness.

Rheometric Scientific has completed assessment of its
manufactured products and internal systems for Year 2000
compliance.  This task was completed during the first
quarter of 1999.  The majority of instruments were found to
be Year 2000 compliant.  Software upgrades for non-compliant
products have been released via customer support and the
Internet.  A

                          12 of 16

<PAGE>

summarized listing of instrument compliance status is posted
on the corporate web site at http://www.rheosci.com, which
includes individual instrument information and results of
internal system evaluations.

All internal systems that have not yet been updated for Year
2000 compliance are being revised or tested at this time.
Computer hardware is being replaced in an ongoing equipment
renewal program.  Some software revisions are being
performed off-site by a Year 2000 consultant. This work has
entered the testing stage, and completion of testing and
implementation is expected during the fourth quarter of
1999. All identified systems have been evaluated, and no
unexpected problems have been encountered at this time.

Rheometric Scientific expects that its products, systems and
suppliers will remain fully operational and will not cause
any material disruptions due to Year 2000 problems.  Because
of the uncertainties associated with assessing preparedness
of suppliers and customers, there is a risk of material
adverse effect on Rheometric's future results of operations
if these constituencies are not capable of correcting their
Year 2000 problems, if any.  Contingency plans are being
developed to address any problems that may become known.

The Company's estimate of the total cost for Year 2000
compliance, based on the work completed to date plus
estimates of remediation costs for systems not yet fully
assessed, is approximately $50,000, of which approximately
$45,500 has been incurred through September 30, 1999.
Incremental spending has not been and is not expected to be
material because most Year 2000 compliance costs will be met
with amounts that are normally budgeted for procurement and
maintenance of the Company's information systems and
production and facilities equipment.  The redirection of
spending from procurement of information systems and
production and facilities equipment to implementation of
Year 2000 compliance plans may in some instances delay
productivity improvements.  The Company presently believes
that the Year 2000 issue will not cause material operational
problems for the Company.   However, if the Company is not
successful in identifying all material Year 2000 problems,
or assessment and remediation of identified Year 2000
problems is not completed in a timely manner, there may be
an interruption in, or failure of, certain normal business
activities or operations.  Such interruptions or failures
could have a material adverse impact on the Company's
consolidated results of operations and financial condition,
or on its relationships with customers, suppliers, or
others.

                          13 OF 16

<PAGE>

                 PART II.  OTHER INFORMATION

Item 6.   Exhibits and Reports on Form 8-K

      (a)Exhibits (numbered in accordance with Item 601 of
          Regulation S-K).

      3.1  Certificate of Incorporation of the Registrant,
           as Amended, incorporated by reference to Exhibit
           3.1 to the Company's Quarterly Report on Form 10-
           Q for the period ended March 31, 1995 (File No.
           0-14617).
      3.2  By-Laws of the Registrant, as Amended,
           incorporated by reference to Exhibit 3.2 to the
           Company's Annual Report on Form 10-K for the
           year ended December 31, 1993 (File No. 0-14617).
      4.1  Specimen Certificate representing Common Stock
           of the Registrant, incorporated by reference to
           the exhibits to the Company's Registration
           Statement on Form S-1, File No. 33-807 filed on
           October 10, 1985.
      4.2  Warrant to Purchase 132,617 shares Common Stock of
           Rheometric Scientific, Inc. issued to RSI (NJ) QRS 12-13,
           Inc., incorporated by reference to Exhibit 1 to the
           Company's Current Report on Form 8-K dated February 23, 1996
           (File No. 0-14617).
      4.3  Warrant to Purchase 331,543 shares of Common Stock of
           Rheometric Scientific, Inc. issued to RSI (NJ) QRS 12-13,
           Inc., incorporated by reference to Exhibit 2 to the
           Company's Current Report on Form 8-K dated February 23, 1996
           (File No. 0-14617).
     *4.4  Rheometric Scientific, Inc. 1996 Stock
           Option Plan, incorporated by reference to
           Exhibit 4.3 to the Company's Quarterly Report on
           Form 10-Q for the period ended June 30, 1996
           (File No. 0-14617).
     *10.1 Amended and Restated Employment Agreement
           between Ronald F. Garritano and the Company
           incorporated by reference to Exhibit 10.3 to the
           Company's Annual Report on Form 10-K dated
           December 31, 1997 (File No. 0-14617).
     *10.2 Employment Agreement between Matthew Bilt
           and the Company, incorporated by reference to
           Exhibit 10.4 to the Company's Quarterly Report
           on Form 10-Q for the period ended September 30,
           1996 (File No. 0-14617).
     *10.3 Employment Agreement between Joseph Musanti and
           the Company incorporated by reference to Exhibit
           10.4 to the Company's Annual Report on Form 10-K
           dated December 31, 1997 (File No. 0-14617).
     10.4  Loan and Security Agreement with Fleet Capital
           Corporation dated February 23, 1996,
           incorporated by reference to Exhibit 1 to the
           Company's Current Report on Form 8-K dated
           February 23, 1996 (File No. 0-14617).

                          14 of 16

<PAGE>

     10.5  Lease Agreement by and between RSI (NJ) QRS 12-
           13, Inc., and Rheometric Scientific, Inc. dated as of
           February 23, 1996, incorporated by reference to Exhibit 5 to
           the Company's Current Report on Form 8-K dated February 23,
           1996 (File No. 0-14617).
     10.6  Revolving Credit Facility Note - Fleet Capital
           Corporation, incorporated by reference to Exhibit 6 to the
           Company's Current Report on Form 8-K dated February 23, 1996
           (File No. 0-14617).
     10.7  Subordination Agreement between Axess
           Corporation and Fleet Capital Corporation, incorporated by
           reference to Exhibit 10.26 to the Company's Annual Report on
           Form 10-K dated December 31, 1995 (File No. 0-14617).
     10.8  Subordination Agreement between Axess
           Corporation and RSI (NJ) QRS 12-13, Inc., incorporated by
           reference to Exhibit 10.27 to the Company's Annual Report on
           Form 10-K dated December 31, 1995 (File No. 0-14617).
     10.9  Amended and Restated Subordinated Unsecured
           Working Capital Note - Axess Corporation, incorporated by
           reference to Exhibit 10.28 to the Company's Annual Report on
           Form 10-K dated December 31, 1995 (File No. 0-14617).
     10.10 First Amendment to Lease Agreement dated June 10,
           1996 between RSI (NJ) QRS 12-13, Inc. and Rheometric
           Scientific, Inc. incorporated by reference to Exhibit 10.12
           to the Company's Annual Report on Form 10-K dated December
           31, 1996 (File No. 0-14617).
     10.11 Second Amendment to Lease Agreement dated February
           20, 1997 between RSI (NJ) QRS 12-13, Inc. and Rheometric
           Scientific, Inc. incorporated by reference to Exhibit 10.13
           to the Company's Annual Report on Form 10-K dated December
           31, 1996 (File No. 0-14617).
     10.12 Amendment Letter dated May 2, 1997 by Fleet
           Capital Corporation, amending Sections 9.1(J) and 9.3(D) of
           the Loan and Security Agreement dated February 23, 1996,
           incorporated by reference to Exhibit 10.14 to the Company's
           Annual Report on Form 10-K dated December 31, 1996 (File No.
           0-14617).
     10.13 Amendment Letter dated May 6, 1997 by RSI (NJ) QRS-
           12-13, Inc., amending paragraphs 7 and 8 of Exhibit D to the
           Lease Agreement dated as of February 23, 1996, incorporated
           by reference to Exhibit 10.15 to the Company's Annual Report
           on Form 10-K dated December 31, 1996 (File No. 0-14617).
     10.14 Amendment to Loan and Security Agreement with
           Fleet Capital Corporation dated March 31, 1998 incorporated
           by reference to Exhibit 10.16 to the Company's Annual Report
           on Form 10-K dated December 31, 1997 (File No. 0-14617).
     10.15 Second Amendment to Loan and Security Agreement
           with Fleet Capital Corporation dated February 19, 1999
           incorporated by reference to Exhibit 10.15 to the


                          15 of 16

<PAGE>

           company's Annual Report of Form 10-K dated
           December 31, 1998 (File No. 0-14617).
     10.16 Third Amendment to Loan and Security Agreement
           with Fleet Capital Corporation dated November 12, 1999
           incorporated by reference to Exhibit 10.16 to the company's
           Annual Report on Form 10-K dated December 31, 1998 (File No.
           0-14617).
     23    Consent of Independent Auditors incorporated by
           reference to Exhibit 23 to the Company's Annual
           Report on Form 10-K dated December 31, 1998
           (File No. 0-14617).
     27    Financial Data Schedule


(b)       Reports on Form 8-K:

               None.




                         SIGNATURES

Pursuant to the requirements of the Securities Exchange Act
of 1934, the Registrant has duly caused this report to be
signed on its behalf by the undersigned thereunto duly
authorized.

                            RHEOMETRIC SCIENTIFIC, INC.
                            (Registrant)




January 27, 2000            By /z/ Joseph Musanti
                             Joseph Musanti, Vice President,
                              Finance and Chief Financial Officer




                          16 of 16
<PAGE>


<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from the
Company's consolidated financial statements for the quarter ended September 30,
1999 and is qualified in its entirety by reference to such financial statements.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-END>                               DEC-31-1999
<CASH>                                             628
<SECURITIES>                                         0
<RECEIVABLES>                                    9,753
<ALLOWANCES>                                         0
<INVENTORY>                                      9,509
<CURRENT-ASSETS>                                20,584
<PP&E>                                          15,340
<DEPRECIATION>                                   9,846
<TOTAL-ASSETS>                                  26,929
<CURRENT-LIABILITIES>                           12,970
<BONDS>                                          4,568
                                0
                                          0
<COMMON>                                            13
<OTHER-SE>                                         125
<TOTAL-LIABILITY-AND-EQUITY>                    26,929
<SALES>                                         20,630
<TOTAL-REVENUES>                                20,630
<CGS>                                           11,381
<TOTAL-COSTS>                                   11,381
<OTHER-EXPENSES>                                 9,384
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               1,541
<INCOME-PRETAX>                                (1,745)
<INCOME-TAX>                                         3
<INCOME-CONTINUING>                            (1,748)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (1,748)
<EPS-BASIC>                                     (0.13)
<EPS-DILUTED>                                   (0.13)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission